Experimental Hematology
Volume 38, Issue 6 , Pages 453-461.e1 , June 2010

A novel fluorescent-based assay reveals that thrombopoietin signaling and Bcl-XL influence, respectively, platelet and erythrocyte lifespans

  • Lucy A. Coupland

      Affiliations

    • The John Curtin School of Medical Research, The Australian National University, Canberra, Australia
    • ,
  • Deborah Cromer

      Affiliations

    • Institute for Emerging Infections, James Martin 21st Century School, Zoology Department, Oxford, UK
    • ,
  • Miles P. Davenport

      Affiliations

    • Centre for Vascular Research, University of New South Wales, Sydney, Australia
    • ,
  • Christopher R. Parish

      Affiliations

    • The John Curtin School of Medical Research, The Australian National University, Canberra, Australia
    • Corresponding Author InformationOffprint requests to: Christopher R. Parish, B.Sc., Ph.D., Cancer and Vascular Biology Group, The John Curtin School of Medical Research, Australian National University, PO Box 334, Canberra, ACT 2601, Australia

Received 20 January 2010 ,Revised 2 March 2010 ,Accepted 3 March 2010.

References 

  1. Van Putten LM. The life span of red cells in the rat and the mouse as determined by labeling with DFP32 in vivo. Blood. 1958;13:789–794
  2. Goodman JW, Smith LH. Erythrocyte life span in normal mice and in radiation bone marrow chimeras. Am J Physiol. 1961;200:764–770
  3. Hoffmann-Fezer G, Maschke H, Zeitler HJ, et al. Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studies. Ann Hematol. 1991;63:214–217
  4. Heilmann E, Friese P, Anderson S, et al. Biotinylated platelets: a new approach to the measurement of platelet life span. Br J Haematol. 1993;85:729–735
  5. Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A. 1996;93:11877–11882
  6. Baker GR, Sullam PM, Levin J. A simple, fluorescent method to internally label platelets suitable for physiological measurements. Am J Hematol. 1997;56:17–25
  7. Magnusson S, Hou M, Hallberg EC, Breimer ME, Wadenvik H. Biotinylated platelets have an impaired response to agonists as evidenced by in vitro platelet aggregation tests. Thromb Res. 1998;89:53–58
  8. Berger M. Production of antibodies that bind biotin and inhibit biotin containing enzymes. Biochemistry. 1975;14:2338–2342
  9. Muzykantov VR, Murciano JC, Taylor RP, Atochina EN, Herraez A. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin. Anal Biochem. 1996;241:109–119
  10. Dale GL, Gaddy P, Pikul FJ. Antibodies against biotinylated proteins are present in normal human serum. J Lab Clin Med. 1994;123:365–371
  11. Lotter MG, Heyns AD, Badenhorst PN, et al. Evaluation of mathematic models to assess platelet kinetics. J Nucl Med. 1986;27:1192–1201
  12. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128:1173–1186
  13. Hoffmann-Fezer G, Mysliwietz J, Mortlbauer W, et al. Biotin labeling as an alternative nonradioactive approach to determination of red cell survival. Ann Hematol. 1993;67:81–87
  14. Recommended method for indium-111 platelet survival studies. International Committee for Standardization in Hematology. Panel on Diagnostic Applications of Radionuclides. J Nucl Med. 1988;29:564–566
  15. Murphy EA, Francis ME. The estimation of blood platelet survival. II. The multiple hit model. Thromb Diath Haemorrh. 1971;25:53–80
  16. Carpinelli MR, Hilton DJ, Metcalf D, et al. Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc Natl Acad Sci U S A. 2004;101:6553–6558
  17. Quah BJ, Warren HS, Parish CR. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc. 2007;2:2049–2056
  18. Alugupalli KR, Michelson AD, Barnard MR, Leong JM. Serial determinations of platelet counts in mice by flow cytometry. Thromb Haemost. 2001;86:668–671
  19. Murphy EA, Francis ME. The estimation of blood platelet survival I. General principles of the study of cell survival. Thromb Diath Haemorrh. 1969;22:281–295
  20. Dowling MR, Milutinovic D, Hodgkin PD. Modelling cell lifespan and proliferation: is likelihood to die or to divide independent of age?. J R Soc Interface. 2005;2:517–526
  21. Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol. 1995;23:996–1001
  22. Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood. 1998;92:4446–4452
  23. Marinkovic D, Zhang X, Yalcin S, et al. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J Clin Invest. 2007;117:2133–2144
  24. Abbrecht PH, Littell JK. Erythrocyte life-span in mice acclimatized to different degrees of hypoxia. J Appl Physiol. 1972;32:443–445
  25. Tsukada T, Tango T. On the methods calculating mean survival time in 51Cr-platelet survival study. Am J Hematol. 1980;8:281–290
  26. Recommended methods for radioisotope platelet survival studies: by the panel on Diagnostic Application of Radioisotopes in Hematology, International Committee for Standardization in Hematology. Blood. 1977;50:1137–1144
  27. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood. 1985;66:1105–1109
  28. Majka M, Ratajczak J, Villaire G, et al. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Exp Hematol. 2002;30:751–760
  29. Geddis AE, Linden HM, Kaushansky K. Thrombopoietin: a pan-hematopoietic cytokine. Cytokine Growth Factor Rev. 2002;13:61–73
  30. Alexander WS, Roberts AW, Nicola NA, Li R, Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood. 1996;87:2162–2170
  31. Walsh M, Lutz RJ, Cotter TG, O'Connor R. Erythrocyte survival is promoted by plasma and suppressed by a Bak-derived BH3 peptide that interacts with membrane-associated Bcl-X(L). Blood. 2002;99:3439–3448
  32. Rhodes MM, Kopsombut P, Bondurant MC, Price JO, Koury MJ. Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin. Blood. 2005;106:1857–1863
  33. Wagner KU, Claudio E, Rucker EB, et al. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development. 2000;127:4949–4958

PII: S0301-472X(10)00080-9

doi: 10.1016/j.exphem.2010.03.003

Experimental Hematology
Volume 38, Issue 6 , Pages 453-461.e1 , June 2010

Article Tools

* Image Usage & Resolution